Yahoo Poland Wyszukiwanie w Internecie

Search results

1. pmc.ncbi.nlm.nih.gov › articles › PMC7739555Topical antibiotic therapy in eye infections - myths and...

   pmc.ncbi.nlm.nih.gov › articles › PMC7739555

   Topical ophthalmic treatments include eye drops, ointments and AB gels. They are prescribed by ophthalmologists, but as well by family doctors, paediatricians and doctors from other specialties. Topical ophthalmic ABs are prescribed for both curative and preventive purposes, for EI prophylaxis after ophthalmic surgery.

2. www.ncbi.nlm.nih.gov › pmc › articlesA European Perspective on Topical Ophthalmic Antibiotics: Current...

   www.ncbi.nlm.nih.gov › pmc › articles

   24 paź 2011 · Clinical studies provide relevant data concerning the characteristics and clinical efficacy of antibacterial eye drops in ocular anterior segment infections or for perioperative prophylaxis. Publications were included to cover the current options of antibacterial eye drops available in Europe.

3. www.ncbi.nlm.nih.gov › pmc › articlesAnti-Infective Treatment and Resistance Is Rarely Problematic...

   www.ncbi.nlm.nih.gov › pmc › articles

   6 lut 2022 · The treatment of eye infections is very different than treating other body infections that require systemic anti-infectives. Endophthalmitis, keratitis, conjunctivitis, and other ocular infections are treated with direct injection and with topical drops directly to the infection site.

4. www.ncbi.nlm.nih.gov › pmc › articlesCiprofloxacin-loaded Bioadhesive Hydrogels for Ocular...

   www.ncbi.nlm.nih.gov › pmc › articles

   9 wrz 2020 · In this study, we aim to further investigate the capability of GelCORE in the prevention of eye infection by loading micelles (MCs) containing ciprofloxacin (CPX), a broad-spectrum antibiotic, within the bioadhesive.

5. pubmed.ncbi.nlm.nih.gov › 8353434Evaluation of efficacy and safety of ciprofloxacin ophthalmic...

   pubmed.ncbi.nlm.nih.gov › 8353434

   The results of this clinical study demonstrate that ciprofloxacin ophthalmic solution 0.3% is as safe and as effective as 0.5% chloramphenicol ophthalmic solution in the treatment of conjunctivitis and blepharitis of bacterial aetiology.

6. pubmed.ncbi.nlm.nih.gov › 8942881Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified...

   pubmed.ncbi.nlm.nih.gov › 8942881

   Ciprofloxacin ophthalmic solution 0.3% monotherapy is equivalent clinically and statistically to standard therapy (fortified tobramycin-cefazolin) for the treatment of bacterial corneal ulcers and produces significantly less discomfort.

7. pubmed.ncbi.nlm.nih.gov › 8997576Ciprofloxacin ophthalmic solution in the treatment of...

   pubmed.ncbi.nlm.nih.gov › 8997576

   The efficacy and safety of ciprofloxacin ophthalmic solution (0.3%) and fusidic acid gel (1%) were compared in the treatment of bacterial conjunctivitis and blepharitis in a randomized, open, parallel group study.